BioNTech SE AI Forecast for 2026-2030
AI price forecast for BioNTech SE for 2026-2030 based on technical analysis, on-chain metrics, and market sentiment analysis.
BioNTech SE (BNTX) is trading at $91.99, ranked #58 by market cap. Over the last 30 days it has moved +0.0%, giving it a neutral short-term outlook with a very high risk profile. Measured against its all-time high of $124.00 and current momentum, our model projects an average BNTX price of $134.81 by 2030.
Current Price
$91.99
ATH: $124.00 (74%)
Sentiment
Neutral
Momentum: +1%
Tech Signal
SELL
3/8 of 8 indicators
Risk Level
Very High
Volatility: 0.6% / day
BioNTech SE Price Forecast 2026
Pessimistic
$80.30
-12.7%
Average
$91.99
+0.0%
Optimistic
$113.90
+23.8%
Yearly Forecast
| Year | Min | Avg | Max | Growth Potential |
|---|---|---|---|---|
| 2026 | $80.30 | $91.99 | $113.90 | +0% |
| 2027 | $78.64 | $101.21 | $143.54 | +10% |
| 2028 | $95.67 | $111.36 | $166.23 | +21% |
| 2029 | $97.51 | $122.53 | $189.91 | +33% |
| 2030 | $99.35 | $134.81 | $215.46 | +47% |
| 2031 | $101.19 | $148.33 | $243.36 | +61% |
| 2032 | $107.54 | $171.19 | $290.52 | +86% |
| 2033 | $112.04 | $181.66 | $312.18 | +97% |
| 2034 | $115.66 | $190.12 | $329.74 | +107% |
| 2035 | $118.82 | $197.57 | $345.21 | +115% |
| 2040 | $131.58 | $228.01 | $372.00 | +148% |
| 2050 | $151.51 | $277.04 | $512.42 | +201% |
AI Forecast Factors
Volatility
6%
Momentum
+1%
ATH Potential
1.3x
Room to ATH
Market Rank
#58
Factor: 2.00x
Scarcity
1.00x
Supply factor
Liquidity
0%
Bullish Factors
- Trading 26% below its all-time high of $124.00 leaves substantial recovery upside.
- Growing adoption and expanding use cases continue to strengthen the long-term outlook for BioNTech SE.
- Improving market structure and rising institutional participation add support for BNTX over the forecast horizon.
- At rank #58, BioNTech SE retains room to climb as capital rotates into quality assets.
- A constructive macro backdrop could accelerate the next leg higher for BioNTech SE.
Bearish Factors
- A market rank of #58 implies lower liquidity and higher sensitivity to broad market swings.
- Thin trading volume relative to market cap can amplify price swings in both directions.
- Broader market corrections and shifting macro conditions could weigh on BioNTech SE.
- Regulatory uncertainty across key jurisdictions remains a persistent risk for BNTX.
- Competition from rival projects could cap BioNTech SE's upside if execution slows.
Frequently Asked Questions
Is BioNTech SE a good investment in 2026?
BioNTech SE currently shows a neutral outlook with a very high risk profile. Our model projects an average price near $91.99 in 2026, though BNTX remains volatile — always do your own research.
What is the BioNTech SE price prediction for 2030?
For 2030 our AI model forecasts BNTX between $99.35 and $215.46, with an average target of $134.81.
How high can BioNTech SE realistically go?
In the most optimistic long-term scenario, BioNTech SE could reach around $512.42. This assumes strong adoption and favorable market conditions.
Why is the BioNTech SE forecast neutral?
This read is driven by current momentum of +1%, the distance to its all-time high, and a market position at rank #58.
Disclaimer
All forecasts and analytical data on Web3Forecast are provided for informational purposes only and do not constitute financial advice. Cryptocurrency investments carry high risk. Always do your own research before making investment decisions.